UM school of medicine surgeon-scientists to co-lead large international clinical trial to determine most effective treatment for common hip fracture in older adults
Many physicians are now using algorithms that consider a patient鈥檚 sex, like heart disease risk assessment tools, to help with clinical decision-making. Reliance on these algorithms may result in men and women receiving different care or having different eligibility for healthcare resources, for example placement on an organ transplant list.
Continuing significant advancements in the field of xenotransplantation, surgeon-scientists from the University of Maryland School of Medicine provided an extensive analysis on the second patient in the world to receive a genetically-modified pig organ. Lawrence Faucette, 58, received a pig heart at the University of Maryland Medical Center in 2023 to treat his end-stage heart failure. He lived for 40 days before choosing to forgo additional treatment after the transplant began to fail due to rejection.
New Study Found Increased Medical Visits for Heart and Respiratory Problems in Baltimore on Poor Air Quality Days from Western Canadian Wildfires
In a study published in the Dec. 5 issue of Nature, a team of researchers discovered a new population of neurons that is responsive to the hormone leptin. Leptin responsive neurons are important in obesity since leptin is sent to the brain from the body鈥檚 fat stores to suppress hunger.
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, has announced that prominent business leader and philanthropist Michael Greenebaum has been named Chair of the School's Board of Visitors. Mr. Greenebaum served as the Inaugural Vice Chair of the Board of Visitors since 2021 and has been a board member since 2012.
Adolescents who snore frequently were more likely to exhibit behavior problems such as inattention, rule-breaking, and aggression, but they do not have any decline in their cognitive abilities, according to a new study conducted by researchers at the University of Maryland School of Medicine (UMSOM).
University of Maryland School of Medicine Researchers Identify Neurobiological Changes Leading to Increase Release of the Brain Chemical Dopamine and Its Target Neurons Linked to Addiction-Like Behavior With the increased legalization of recreational cannabis, as many as 1 in 5 pregnant women in the U.S. are now using the drug to help with morning sickness, lower back pain or anxiety.
Researchers at the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine (UMSOM) have developed a broad and deep genomic database of Latin Americans which gathers genome-wide data of Latin American populations into a single source and allows other scientists to easily add that population to their own research studies without straining budgets.
Margaret M. McCarthy, PhD, an internationally-recognized neuroscientist, who is the James and Carolyn Frenkil Dean鈥檚 Endowed Professor in the University of Maryland School of Medicine's Department of Pharmacology, Physiology, and Drug Development, and Director of the University of Maryland 鈥� Medicine Institute of Neuroscience Discovery (UM-MIND), has been elected as a new member of the National Academy of Medicine.
With a commitment to addressing rural health disparities and the challenges faced by Maryland鈥檚 rural Eastern Shore residents, the University of Maryland School of Medicine has launched the Rural Health Equity and Access Longitudinal Elective (R-HEALE).
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, announced today that the School of Medicine has been awarded $2 million in matching funds from the Maryland E-Nnovation Initiative Fund (MEIF), administered by the Maryland Department of Commerce. The funds, totaling $4 million when combined with UMB qualified funding, will enable the establishment of three endowed research professorships.
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, has announced the formation of a new Department of Pharmacology, Physiology and Drug Development, which merges the Department of Physiology and Department of Pharmacology. This new Department aligns the basic science research efforts of both entities with a strong emphasis on the development of new drug therapies.
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today the appointment of Elana J. Fertig, PhD, FAIMBE, as the new Director of the School鈥檚 Institute for Genome Sciences (IGS).
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today the appointment of Kelly Dunn, PhD, MBA, one of the nation鈥檚 leading researchers on opioid use disorder, as the inaugural Director of the School鈥檚 Kahlert Institute for Addiction Medicine
Study: Living in Disadvantaged Neighborhoods Influences Stress-Related Genes, Which May Contribute to Aggressive Prostate Cancer in African American Men
Millions of patients worldwide suffer from a chronic itching condition with no identifiable cause 鈥� a condition known as chronic pruritus of unknown origin (CPUO) 鈥� that has no targeted therapies approved to treat it. Many of these patients suffer for years with little relief, but a new University of Maryland School of Medicine study may provide hope for future treatments. Patients were found to have lower than normal levels of metabolite biomarkers in the blood plasma that could point to a cause of their excruciating symptoms.
Dr. Henn is Established Academic Leader with Strong Track Record of Success in Research and Clinical Care; Led Department鈥檚 Residency Program to Become Among Top in the Nation
New Leased Space Will Include Adult and Pediatric Primary Care, Mental Health Services, Prenatal Care, and Nutrition Counseling
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 海角社区 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right